Sublingual immunotherapy, often shortened to SLIT, is allergy treatment you hold under your tongue instead of taking as a shot. Small, repeated doses of an allergen are meant to retrain the immune system over years, not to settle symptoms today. In the United States it is sold in three very different forms, and only one of them is FDA approved.
Start with that status, because it changes everything else on the page. A small group of prescription tablets carry FDA approval for specific pollen and dust mite allergies. Liquid allergy drops are widely used by allergists, but sublingual dosing of extracts licensed for injection is an off-label use. And some products sold over the counter put the phrase on homeopathic labels, including the pet dander product whose listing appears on this page. Homeopathic drugs are not reviewed by the FDA for safety or effectiveness before they go on sale.
What sublingual immunotherapy actually is
Antihistamines, nasal steroids and eye drops block or calm an allergic reaction after it starts. Immunotherapy tries to change the reaction itself. You take a measured amount of the thing you react to, on a schedule, for a long time. The immune system slowly learns to treat that protein as harmless.
The sublingual route means the dose sits under your tongue and dissolves there before you swallow. The tissue under the tongue is rich in immune cells that promote tolerance, which is why this route was studied in the first place. Because doses are taken at home, the daily routine is yours to keep, not a clinic’s.
The main target is allergic rhinitis, the runny nose, sneezing, congestion and itchy eyes caused by pollen, dust mites or animal dander. Some products also help allergic conjunctivitis, the eye symptoms that travel with it. Treatment is not a rescue medicine. It does nothing for a reaction that is happening right now, and many people still use their usual allergy medicines during the first season.
Two more things separate this from a quick fix. It is slow, measured in months and years rather than days. And it is specific: a dust mite product does nothing for ragweed, so an accurate diagnosis comes first. A patient-facing summary of how the route works is kept by the Cleveland Clinic.
Three products share one name
Most confusion about this treatment comes from lumping three product classes together. They differ in regulation, evidence, oversight and price, so it is worth separating them before you shop.
| Type | What it is | Regulatory status | How people get it |
|---|---|---|---|
| Prescription tablets | Standardised allergen extract in a fast-dissolving tablet for one allergen family | FDA approved for specific allergic rhinitis indications | Prescriber visit, first dose taken in a medical setting |
| Liquid allergy drops | Allergen extracts, often mixed to match your test results, dosed by drops or a spray | Extracts are FDA licensed, but sublingual use is off label | Allergist or an online allergy program, usually a subscription |
| Homeopathic sprays and drops | Highly diluted preparations sold over the counter, sometimes named for a trigger such as pet dander | Homeopathic products are not FDA reviewed for safety or effectiveness before sale | Retail shelves and websites, no prescription |
The approved tablets are real drugs with full labels, boxed warnings and clinical trial data behind them. In the US they cover grass pollens, short ragweed and house dust mite. There is no approved tablet for cat or dog dander, which is why pet allergy is usually handled with custom drops or injections instead.
Custom drops sit in a grey zone. The extracts themselves are licensed biologics, but they are licensed for injection under the skin. Using them under the tongue is a physician decision, not an FDA-cleared route, and dosing is not standardised across clinics. The FDA keeps its list of licensed allergenic products and their cleared uses on the agency’s allergenics page.
The homeopathic products are different again. The over-the-counter listing attached to this page describes a homeopathic dilution meant to support immune function in infants, children and adults, with a note that the claim has not been evaluated by the FDA. That is not the same as desensitising you to an allergen, and it is not an approved allergy indication. Its own label tells you to stop and ask a doctor if symptoms get worse or fail to improve after five days, and to check with a health professional first if you are pregnant or breastfeeding. Homeopathic listings sometimes carry odd class codes in federal databases, because they are entered without an approval review. Background on how these products are regulated is published by the FDA, and the NIH centre for complementary health summarises the evidence base.
Food allergy is a fourth conversation. Under-the-tongue dosing for peanut and other foods is still research territory in specialist centres, as FARE explains for families. Do not attempt any version of it at home.
How it works, and what the tablets are approved to treat
Under the tongue, immune cells pick up the allergen and carry it to nearby lymph nodes. With repeated exposure, the body makes more regulatory T cells and shifts antibody production away from the IgE that drives allergy symptoms. The reaction does not vanish overnight; it dampens as tolerance builds. Researchers have reviewed this mechanism and its clinical use in an open-access NCBI-hosted paper.
The approved sublingual allergy tablets are indicated for allergic rhinitis, with or without eye symptoms, caused by the allergen on that specific label. Approval requires proof that you are actually sensitised, either through a positive skin test or a blood test for allergen-specific IgE. Guessing at your trigger is not enough.
Three limits appear on those labels and matter in practice. First, none of them is for immediate symptom relief. Second, they are not asthma treatments, even though allergy and asthma often travel together. Third, each label sets its own age range, and each has a start-time rule: grass and ragweed tablets are begun months before the expected pollen season and continued through it, while the dust mite tablet is taken year round. Full prescribing information for each product is searchable on DailyMed, and the label is the authority on timing, dose and age.
Custom drops are prescribed on the same diagnostic logic, matched to your test results, but the schedule is set by the clinic rather than by an approved label. That flexibility is the appeal for people allergic to several things at once, including animals and moulds. It is also why two programs can hand you very different bottles for the same test results.
How well it works, and how long treatment lasts
There is no honest single success rate, and any program quoting one is doing marketing. Trials measure average symptom scores plus how much rescue medicine people needed, then compare that with placebo. Across those trials, sublingual immunotherapy produced modest average improvements in nasal and eye symptoms and reduced medication use for many participants. Averages hide a wide spread: some people notice a clear change, some notice little.
Timing matters more than most people expect. Seasonal products are started well before pollen arrives, so the first real test comes during that season. Benefit often builds across a second and third season rather than appearing in week one. Because of that, allergists commonly continue treatment for about three to five years, aiming for relief that lasts after dosing stops. A plain-language overview of allergy drops and their timelines is published by Johns Hopkins Medicine.
Adherence is the weak point of the whole approach. A daily dose taken at home, for years, with no immediate reward, is easy to drop. Missed doses can mean restarting under supervision, so ask what your program’s rule is before you travel or take a break.
Evidence quality also differs by product class. The approved tablets have controlled trials and fixed potency behind them. Custom drops rely on smaller studies and clinical experience, and their concentrations vary between pharmacies and practices. The AAAAI patient video library covers the professional view. Treat homeopathic dilutions separately: they are not dosed to desensitise, so evidence for allergy improvement should not be borrowed from tablet or drop research.
Side effects and the warnings that matter most
Most unwanted effects happen in the mouth and throat, where the dose lands. Reported reactions include itching or tingling of the mouth, an itchy or swollen tongue or lips, throat irritation, itchy ears, nausea and stomach discomfort. These are usually mild to moderate, show up in the first days or weeks, and settle as treatment continues. Some clinicians suggest taking the first doses with food or drink kept out of the way for a short period; follow the label and your prescriber.
The serious risk is the reason approved sublingual immunotherapy tablets carry a boxed warning, the FDA’s strongest label alert. Severe allergic reactions, including anaphylaxis and severe tightening of the throat and voice box, have occurred. Because of that, the first dose is taken in a medical setting where staff watch you for a period stated on the label, commonly around 30 minutes, and an epinephrine auto-injector is prescribed alongside the tablet with training on how to use it.
Labelled contraindications are specific and worth reading in full. The approved tablets are not for people with severe, unstable or uncontrolled asthma, for anyone who has had a previous severe systemic allergic reaction or severe local reaction to sublingual allergen immunotherapy, or for anyone with a history of eosinophilic esophagitis, an allergic inflammation of the swallowing tube. Sores, cuts or recent dental surgery in the mouth are usually a reason to pause dosing until healing is complete. Asthma that flares needs attention before the next dose.
Interactions are less about other pills and more about what could mask or worsen a reaction. Tell your clinician about beta blockers and other blood pressure drugs, because they can complicate treatment of anaphylaxis, and about any medicine that suppresses the immune system. Pregnancy, breastfeeding and planned pregnancy belong in that conversation too. General allergy and treatment background for patients is maintained on MedlinePlus.
Allergy drops compared with allergy shots
Allergen injections, known as subcutaneous immunotherapy, are the older and better-covered route. The comparison is less about which one wins and more about which trade-offs you can live with.
| Factor | Under-the-tongue dosing | Allergen injections |
|---|---|---|
| Where doses happen | At home daily, after a supervised first dose for tablets | In a clinic, with a waiting period after each shot |
| Visit burden | Low once started | Frequent visits during build-up, then spaced maintenance |
| Reaction pattern | Mostly mouth and throat reactions; systemic reactions reported less often, but they do happen | Local swelling common; systemic reactions are the reason for clinic observation |
| Allergen coverage | Approved tablets cover a narrow set; custom drops can be mixed more broadly | Mixes can cover many allergens, including animals and moulds |
| Regulatory footing | Approved for specific tablets; off label for sublingual drops | Long-standing approved route for licensed extracts |
| Billing shape | Pharmacy benefit for tablets; drops are often paid out of pocket | Usually billed as medical care, per visit and per extract preparation |
For needle-averse adults and young children, home dosing is the obvious draw. For people who react to a long list of triggers, or who already know injections work for them, the clinic route may still fit better. Neither route is a cure you can count on, and both depend on sticking with it for years.
Sublingual Immunotherapy: Drops vs. Shots
| Under-the-Tongue Dosing | Allergen Injections | |
|---|---|---|
| Where doses happen | At home daily (first tablet dose supervised) | In clinic with waiting period each visit |
| Visit burden | Low once started | Frequent build-up visits, then spaced maintenance |
| Reaction pattern | Mostly mouth/throat; systemic reactions less common but possible | Local swelling common; systemic reactions require clinic observation |
| Allergen coverage | Approved tablets: narrow set; custom drops broader | Mixes can cover many allergens including animals and moulds |
| Regulatory footing | Approved for specific tablets; off label for drops | Long-standing approved route for licensed extracts |
| Billing | Pharmacy benefit for tablets; drops often out of pocket | Usually billed as medical care per visit and extract prep |
One practical note on switching. If you have had a severe reaction to injections, that history can rule out sublingual tablets, so bring the records rather than the story. And if you are starting from scratch, ask whether testing was done well enough to justify either route.
What drives the cost, and whether insurance pays
No verified self-pay figure for this treatment appears in the pricing data behind this page, so no monthly number is quoted here. What can be spelled out is the shape of the bill and where the money goes, because that is what changes your total. Advertised prices also move, so treat any quote you find as a snapshot.
Six things drive cost. A branded prescription tablet is priced as a drug through a pharmacy, while custom drops are usually sold as a flat monthly or quarterly subscription. Testing is often separate, whether that is a blood panel or in-office skin testing. The number of allergens in a mix can change what a pharmacy charges. Consultation and follow-up fees may be bundled or billed on their own. Shipping and refill timing affect the yearly figure more than the headline monthly one. And introductory pricing sometimes renews higher, which only shows up on the second bill.
Because the two routes are billed so differently, a yearly view is the only fair comparison. If you are weighing a monthly drop subscription against per-visit injection billing, work out what each looks like over twelve months.
What a year actually costs
Programmes quote a monthly headline. Add the medication, the labs and the renewal price and the real number is usually different.
Advertised prices change often and intro pricing rarely lasts. Ask what the renewal rate is before you commit to a plan.
Coverage is the other half of the question. Approved tablets are drugs, so they may sit on a plan’s pharmacy formulary, often behind prior authorization or step therapy that asks you to try cheaper options first. Sublingual drops are the harder case: because the sublingual route is off label, plans frequently decline them, and many patients pay cash. Injections are more often billed as medical care. None of that is a promise. Call your plan, ask about your specific product and the exact billing codes your clinic will submit, and get the answer in writing. If you want to see how a plan route stacks up against paying cash for the same year, compare the two totals side by side.
Insurance or cash pay, which is cheaper
Going through insurance is not automatically cheaper. Deductibles, copays and prior authorisation can make a cash-pay programme the better deal.
Coverage is never something a programme can promise: plans decide, prior authorisation is routine for GLP-1 medicines, and denials are common. Confirm with your own plan before choosing.
How online allergy programs handle treatment
Telehealth allergy programs have made sublingual immunotherapy much easier to start, and they are not all built the same way. Most begin with testing you do at home, usually a finger-stick blood sample for allergen-specific IgE or a mailed skin-test kit, then ship drops mixed to those results on a repeating schedule.
Six dimensions separate one program from the next. Who reads your results, and are they a licensed clinician in your state. Whether testing is included in the fee or billed separately. Which pharmacy prepares the extract, and whether that is disclosed. What the monthly charge actually includes: bottles only, or follow-up visits and dose adjustments too. How refills, missed doses and travel are handled. And what happens if you react: whether an emergency plan is written down and whether epinephrine is discussed.
One thing telemedicine cannot shortcut is the supervised first dose for approved tablets, which the label places in a medical setting. A program that offers a fully remote start should be able to explain exactly which product it is prescribing and why. State licensure rules also decide where a program can prescribe at all, so availability varies by where you live.
If you are comparing programs, our Telehealth Provider Directory lists what is tracked for each one, and the Scoring Dimensions Explained page sets out how value, clinical depth, trust, access and support are weighted. Cost worksheets and comparison tools live under Free Patient Calculators, and you can request a Sample Savings Report to see the format used for self-pay comparisons. For other compounds, start from the Medication Guide Index. Longer analysis pieces sit in Editorial Coverage, and if you also track metabolic care, the Ranked GLP-1 Program Comparison shows the same factor-by-factor method applied to a busier category.
Questions to ask before your first dose, and when to get help
Bring a short list to the appointment. It saves months of guessing later.
Questions to Ask Before Your First Dose
- Which product am I being prescribed: FDA-approved tablet, custom off-label extract, or something else?
- What test confirmed my trigger, and can I see the results?
- Where do I take the first dose, and how long will I be watched?
- Will I get an epinephrine auto-injector with training on how to use it?
- Does my asthma need better control before I start?
- How long is the planned course, and how will we judge if it's working?
- Which pharmacy prepares my extract, and what is included in the monthly charge?
- Will this be billed to my insurance or paid out of pocket, and what happens at renewal?
- Which product am I being prescribed: an FDA-approved tablet, a custom extract used off label, or something else entirely?
- What test confirmed my trigger, and can I see the results?
- Where do I take the first dose, and how long will I be watched?
- Will I get an epinephrine auto-injector, and can someone show me how to use it?
- Does my asthma need to be better controlled before I start?
- How long is the planned course, and how will we judge whether it is working?
- What do I do about a missed dose, a mouth ulcer, dental work, or travel?
- Which pharmacy prepares my extract, and what is included in the monthly charge?
- Will this be billed to my plan or paid out of pocket, and what happens at renewal?
Then know your stop signals. Trouble breathing or swallowing, throat tightness or a hoarse or changed voice, swelling of the tongue, lips or face, widespread hives, vomiting, dizziness or fainting after a dose all need emergency care, not a wait-and-see. In the US, call 911. Stop dosing and contact your clinician for persistent heartburn, chest or upper abdominal pain, food sticking on the way down, or ongoing vomiting, since those can point to inflammation of the swallowing tube. Worsening asthma, mouth reactions that do not settle, or symptoms that are no better after the timeframe your label or clinician gave you are all worth a call rather than another month of hoping.
Authoritative sources
Prescribing information for the approved products is the final word on indications, warnings and schedules. The FDA publishes product detail for each licensed allergenic, including t
